Acne, Vulgaris

Acne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation

Veröffentlicht: 07.08.2025 um 18:09 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/acne-vulgaris-market-to-register-sustainable-growth-by-2034-examines-delveinsight--key-companies---dermata-therapeutics-astrazeneca-novartis-pharmaceuticals-ucb-pharma-incyte-corporation-302155865.html

en | BE0003739530 | ACNE | boerse | 67920822 |